{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T16:11:39Z","timestamp":1699978299575},"reference-count":10,"publisher":"American Diabetes Association","issue":"1","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2008,1,1]]},"DOI":"10.2337\/dc07-0641","type":"journal-article","created":{"date-parts":[[2007,12,28]],"date-time":"2007-12-28T16:54:25Z","timestamp":1198860865000},"page":"39-40","update-policy":"http:\/\/dx.doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":2,"title":["Clinical Experience With the Addition of Pramlintide in Patients With Insulin-Requiring Type 2 Diabetes"],"prefix":"10.2337","volume":"31","author":[{"given":"Karen","family":"Elkind-Hirsch","sequence":"first","affiliation":[{"name":"Metabolic Center of Louisiana Research Foundation, Baton Rouge, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William J.","family":"Butler","sequence":"additional","affiliation":[{"name":"Metabolic Center of Louisiana Research Foundation, Baton Rouge, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhu","family":"Bhushan","sequence":"additional","affiliation":[{"name":"Metabolic Center of Louisiana Research Foundation, Baton Rouge, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Hirsch","sequence":"additional","affiliation":[{"name":"Metabolic Center of Louisiana Research Foundation, Baton Rouge, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajat","family":"Bhushan","sequence":"additional","affiliation":[{"name":"Metabolic Center of Louisiana Research Foundation, Baton Rouge, Louisiana"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1167","reference":[{"key":"2022031218523475100_R1","unstructured":"Pramlintide [prescribing information]. San Diego, CA, Amylin Pharmaceuticals, Inc., 2005"},{"key":"2022031218523475100_R2","doi-asserted-by":"crossref","unstructured":"Weyer C, Maggs DG, Young AA, Kolterman OG: Amylin replacement with pramlintide as an adjunct to insulin therapy in type 1 and type 2 diabetes mellitus: a physiological approach toward improved metabolic control. Curr Pharm Des\u20087:1353\u20131373, 2001","DOI":"10.2174\/1381612013397357"},{"key":"2022031218523475100_R3","doi-asserted-by":"crossref","unstructured":"Fineman M, Weyer C, Maggs DG, Strobel S, Kolterman OG: The human amylin analog corrects postprandial hyperglucagonemia in patients with type 2 diabetes mellitus. Horm Metab Res\u200834:504\u2013508, 2002","DOI":"10.1055\/s-2002-34790"},{"key":"2022031218523475100_R4","doi-asserted-by":"crossref","unstructured":"Thompson RG, Pearson L, Schoenfeld SL, Kolterman OG: Pramlintide, a synthetic analog of human amylin, improves the metabolic profile of patients with type 2 diabetes using insulin: the Pramlintide in Type 2 Diabetes Group. Diabetes Care\u200821:987\u2013993, 1998","DOI":"10.2337\/diacare.21.6.987"},{"key":"2022031218523475100_R5","doi-asserted-by":"crossref","unstructured":"Buse JB, Weyer C, Maggs DG: Amylin replacement with pramlintide in type 1 and type 2 diabetes: a physiological approach to overcome barriers with insulin therapy. Clinical Diabetes\u200820:137\u2013144, 2002","DOI":"10.2337\/diaclin.20.3.137"},{"key":"2022031218523475100_R6","doi-asserted-by":"crossref","unstructured":"Hollander P, Ratner R, Fineman M, Strobel S, Shen L, Maggs D, Kolterman O, Weyer C: Addition of pramlintide to insulin therapy lowers HbA1c in conjunction with weight loss in patients with type 2 diabetes approaching glycaemic targets. Diabetes Obes Metab\u20085:408\u2013414, 2003","DOI":"10.1046\/j.1463-1326.2003.00295.x"},{"key":"2022031218523475100_R7","doi-asserted-by":"crossref","unstructured":"Hollander PA, Levy P, Fineman MS, Maggs DG, Shen LZ, Strobel SA, Weyer C, Kolterman OG: Pramlintide as an adjunct to insulin therapy improves long-term glycemic and weight control in patients with type 2 diabetes: a 1-year randomized controlled trial. Diabetes Care\u200826:784\u2013790, 2003","DOI":"10.2337\/diacare.26.3.784"},{"key":"2022031218523475100_R8","doi-asserted-by":"crossref","unstructured":"Ratner RE, Want LL, Fineman MS, Velte MJ, Ruggles JA, Gottlieb A, Weyer C, Kolterman OG: Adjunctive therapy with the amylin analogue pramlintide leads to a combined improvement in glycemic and weight control in insulin-treated subjects with type 2 diabetes. Diabetes Technol Ther\u20084:51\u201361, 2002","DOI":"10.1089\/15209150252924094"},{"key":"2022031218523475100_R9","doi-asserted-by":"crossref","unstructured":"Garber AJ, Duncan TG, Goodman AM, Mills DJ, Rohlf JL: Efficacy of metformin in type II diabetes: results of a double-blind, placebo-controlled, dose-response trial. Am J Med\u2008103:491\u2013497, 1997","DOI":"10.1016\/S0002-9343(97)00254-4"},{"key":"2022031218523475100_R10","doi-asserted-by":"crossref","unstructured":"Aviles-Santa L, Sinding J, Raskin P: Effects of metformin in patients with poorly controlled, insulin-treated type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial. Ann Intern Med\u2008131:182\u2013188, 1999","DOI":"10.7326\/0003-4819-131-3-199908030-00004"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/1\/39\/598314\/zdc00108000039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/31\/1\/39\/598314\/zdc00108000039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,12]],"date-time":"2022-03-12T19:58:37Z","timestamp":1647115117000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/31\/1\/39\/27940\/Clinical-Experience-With-the-Addition-of"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc07-0641","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,1,1]]}}}